Phase 2a clinical trial describes safety and efficacy of dendrimer nanotherapy in severe COVID-19 patients
A multicenter, randomized, placebo-controlled phase 2a clinical trial has recently been conducted to evaluate the efficacy of a nanotherapeutic compound ...
